Tag: Blood Cancer
Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne
Two presentations on omidubicel (formerly known as NiCord®),
an investigational advanced cell therapy in Phase 3 clinical development
designed to enhance the life-saving benefits of hematopoietic stem cell (bone
marrow) transplant, developed by Gamida Cell Ltd., a leading cellular and
immune therapeutics company,...
Be The Match® And Gift Of Life® Marrow Registry To Open Blood Stem Cell...
Be The Match® and Gift of Life® Marrow Registry, intend to open, in
late July, the first registry-operated blood stem cell collection facility in
Boca Raton, Florida. The Gift of Life - Be The Match Collection Center brings
to life a new...
ExCellThera Presented ECT-001 Enhanced Cord Blood Transplant For Patients With Blood Cancers At ASH
ExCellThera Inc., presented data on the company’s Phase I/II clinical trial using its lead technology, ECT-001, for allogeneic stem cell transplant at the 60th American Society of Hematology (ASH) Meeting, this December in San Diego, USA. Founded in 2015, headquartered...
